MonoGrippol-plus
MonoGrippol-plus Uses, Dosage, Side Effects, Food Interaction and all others data.
Azoximer bromide is under investigation in clinical trial NCT04381377 (Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19).
| Trade Name | MonoGrippol-plus |
| Generic | Azoximer Bromide + Vaccine Influenza Virus Inactivated |
| Type | |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Russia |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here MonoGrippol-plus
